These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 25339382)
1. Improving heart function by modulating myocardiocyte autophagy: a possible novel mechanism for cardiovascular protection of high-density lipoprotein. Wang F; Ye P Lipids Health Dis; 2014 Oct; 13():163. PubMed ID: 25339382 [TBL] [Abstract][Full Text] [Related]
2. High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Tao R; Hoover HE; Honbo N; Kalinowski M; Alano CC; Karliner JS; Raffai R Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1022-8. PubMed ID: 20061542 [TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate. Brinck JW; Thomas A; Brulhart-Meynet MC; Lauer E; Frej C; Dahlbäck B; Stenvinkel P; James RW; Frias MA Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178180 [TBL] [Abstract][Full Text] [Related]
4. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942 [TBL] [Abstract][Full Text] [Related]
5. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection. Brinck JW; Thomas A; Lauer E; Jornayvaz FR; Brulhart-Meynet MC; Prost JC; Pataky Z; Löfgren P; Hoffstedt J; Eriksson M; Pramfalk C; Morel S; Kwak BR; van Eck M; James RW; Frias MA Arterioscler Thromb Vasc Biol; 2016 May; 36(5):817-24. PubMed ID: 26966278 [TBL] [Abstract][Full Text] [Related]
6. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. Frias MA; James RW; Gerber-Wicht C; Lang U Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362 [TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. Sattler K; Levkau B Cardiovasc Res; 2009 May; 82(2):201-11. PubMed ID: 19233866 [TBL] [Abstract][Full Text] [Related]
8. Targeting sphingosine-1-phosphate signalling for cardioprotection. Kennedy S; Kane KA; Pyne NJ; Pyne S Curr Opin Pharmacol; 2009 Apr; 9(2):194-201. PubMed ID: 19070545 [TBL] [Abstract][Full Text] [Related]
9. HDL and its sphingosine-1-phosphate content in cardioprotection. Keul P; Sattler K; Levkau B Heart Fail Rev; 2007 Dec; 12(3-4):301-6. PubMed ID: 17554629 [TBL] [Abstract][Full Text] [Related]
11. Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1. Becker S; von Otte S; Robenek H; Diedrich K; Nofer JR Biol Reprod; 2011 Mar; 84(3):604-12. PubMed ID: 20980685 [TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43. Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268 [TBL] [Abstract][Full Text] [Related]
13. HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL. Egom EE; Mamas MA; Soran H Curr Opin Lipidol; 2013 Aug; 24(4):351-6. PubMed ID: 23652570 [TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress. Karliner JS Biochim Biophys Acta; 2013 Jan; 1831(1):203-12. PubMed ID: 22735359 [TBL] [Abstract][Full Text] [Related]
15. Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis. Frias MA; Lang U; Gerber-Wicht C; James RW Cardiovasc Res; 2010 Jan; 85(1):118-26. PubMed ID: 19700468 [TBL] [Abstract][Full Text] [Related]
16. Cardioprotective role of sphingosine-1-phosphate. Knapp M J Physiol Pharmacol; 2011 Dec; 62(6):601-7. PubMed ID: 22314562 [TBL] [Abstract][Full Text] [Related]
17. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. Tatematsu S; Francis SA; Natarajan P; Rader DJ; Saghatelian A; Brown JD; Michel T; Plutzky J Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1788-94. PubMed ID: 23723371 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function. Malchinkhuu E; Sato K; Muraki T; Ishikawa K; Kuwabara A; Okajima F Biochem J; 2003 Mar; 370(Pt 3):817-27. PubMed ID: 12470300 [TBL] [Abstract][Full Text] [Related]
19. HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. Argraves KM; Argraves WS J Lipid Res; 2007 Nov; 48(11):2325-33. PubMed ID: 17698855 [TBL] [Abstract][Full Text] [Related]
20. Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases. Diarte-Añazco EMG; Méndez-Lara KA; Pérez A; Alonso N; Blanco-Vaca F; Julve J Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]